Moreover, the positive correlation between TRPC1 expression and cancer progression provides a therapeutic window of opportunity; TRPC1 expression can be leveraged with magnetic field treatment in combination with DOX administration to achieve greater anti-tumor outcomes. This evidence concerns the gene TRPC1 and cancer.